Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study

BACKGROUND: The effectiveness of the second BNT162b2 (Pfizer–BioNTech) mRNA COVID-19 booster vaccine dose (ie, fourth inoculation) is well established, but its safety has yet to be fully understood. The absence of sufficient vaccine safety information is one of the key contributors to vaccine hesita...

Descripción completa

Detalles Bibliográficos
Autores principales: Yechezkel, Matan, Mofaz, Merav, Painsky, Amichai, Patalon, Tal, Gazit, Sivan, Shmueli, Erez, Yamin, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889528/
https://www.ncbi.nlm.nih.gov/pubmed/36410364
http://dx.doi.org/10.1016/S2213-2600(22)00407-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889528/
https://www.ncbi.nlm.nih.gov/pubmed/36410364
http://dx.doi.org/10.1016/S2213-2600(22)00407-6

Ejemplares similares